Today's Date: Add To Favorites   
Hemispherx Biopharma settles class action securities lawsuits
Securities Class Action | 2010/09/05 14:19

Hemispherx Biopharma agreed Tuesday to settle all of the pending securities class actions against the biotechnology company that had been consolidated in the U.S. District Court for the Eastern District of Pennsylvania.

The proposed settlement requires formal court approval.

Terms of the settlement were not disclosed. Hemispherx (AMEX:HEB) of Philadelphia said the settlement will be paid from the company's insurance coverage and will not result in the payment of any funds by the company. The company said the settlement “expressly is not an admission of any culpability by Hemispherx or its officers.”

The series of lawsuits, according to documents Hemispherx filed with the Securities and Exchange Commission, alleged the company and certain officers misrepresented the status of Hemispherx’s new drug application for Ampligen, an experimental treatment for chronic fatigue syndrome the company has worked on for more than three decades.

Last November, the FDA rejected the company’s new drug application for Ampligen and recommended the company conduct additional studies to demonstrate effectiveness. Hemispherx has stated it is continuing to work with the FDA to address the issues raised by the agency.

[PREV] [1] ..[2497][2498][2499][2500][2501][2502][2503][2504][2505].. [3034] [NEXT]
Securities Class Action
Headline Legal News
Stock Market News
Court News
Court Watch
Legal Interview
Securities Lawyers
Securities Law Firm
Topics in Legal News
Attorney News
Legal Focuses
Legal Marketing
Law Firm News
Investment Fraud Litigation
Unanimous Supreme Court pres..
Trump's lawyers ask judge to..
Three Americans in alleged c..
Spanish court summons prime ..
Supreme Court rejects challe..
Trump hush money trial: Pros..
Trial turns testy as Trump l..
War crimes prosecutor seeks ..
TikTok content creators sue ..
Chad holds presidential elec..
Trump faces prospect of addi..
Retrial of Harvey Weinstein ..
Starbucks appears likely to ..
Supreme Court will weigh ban..
Supreme Court rejects appeal..
Supreme Court restores Trump..

   Lawyer & Law Firm Links
St. Louis Missouri Criminal Defense Lawyer
St. Charles DUI Attorney
New York Adoption Lawyers
New York Foster Care Lawyers
Adoption Pre-Certification
Car Accident Lawyers
Sunnyvale, CA Personal Injury Attorney
Oregon Family Law Attorney
Divorce Lawyer Eugene. Family Law
Family Law in East Greenwich, RI
Divorce Lawyer - Erica S. Janton
Post-Divorce Issues Attorney
Connecticut Special Education Lawyer
   Legal Resource Links
Securities fraud, also known as stock fraud and investment fraud, is a practice that induces investors to make purchase or sale decisions on the basis of false information, frequently resulting in losses, in violation of the securities laws. Securities Arbitration. Generally speaking, securities fraud consists of deceptive practices in the stock and commodity markets, and occurs when investors are enticed to part with their money based on untrue statements.

The content contained on the web site has been prepared by Securities Law News as a service to the internet community and is not intended to constitute legal advice or a substitute for consultation with a licensed legal professional in a particular case. | Affordable Law Firm Website Design by Law Promo